RecruitingNCT05651724

Global Research Initiative for Patients Screening on MASH

Global Research Initiative for Patients Screening on MASH - Implementation of an International Transmural Patient Care Pathway

Sponsor

Julius Clinical

Enrollment

10,000 participants

Start Date

Jun 30, 2023

Study Type

OBSERVATIONAL

Conditions

Obesity Metabolic Syndrome MASLD Arterial Hypertension Type 2 Diabetes Fibrosis, Liver Steatosis of Liver MASH MASH With Fibrosis

Summary

GRIPonMASH will assist (primary) health care providers clinicians to implement the latest patient care pathway, as described by the European Association for the Study of the Liver (EASL), to identify patients at risk of severe metabolic dysfunction-associated steatotic liver disease (MASLD) and to raise awareness. The primary objective is to implement a transmural patient care pathway, in order to identify patients with MASLD and its progressive form metabolic dysfunction-associated steatohepatitis (MASH) in primary care centres and clinics in 10 European countries.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study screens people with conditions like type 2 diabetes, obesity, high blood pressure, or metabolic syndrome for a serious liver condition called MASH (metabolic dysfunction-associated steatohepatitis — essentially a severe form of fatty liver disease). The goal is to understand how common it is in this population. **You may be eligible if...** - You have been newly diagnosed with or are currently being treated for type 2 diabetes, obesity, metabolic syndrome, or high blood pressure - You are willing to undergo liver screening tests **You may NOT be eligible if...** - You have other causes of liver disease (such as alcohol-related or viral liver disease) - You have already been diagnosed with advanced liver disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(13)

Hôpital Erasme, Cliniques Universitaires De Bruxelles

Brussels, Vlaams-brabant, Belgium

Antwerp University Hospital

Antwerp, Belgium

4th internal clinic General University Hospital

Prague, Bohemia, Czechia

Hôpital de la Pitié Salpêtrière

Paris, Il-de-France, France

Universitätsmedizin Mainz

Mainz, Rhineland-Palatinate, Germany

Universitätsklinikum des Saarlandes

Homburg, Saarland, Germany

Harokopio University of Athens

Athens, Greece

Fondazione Policlinico Universitario Agostino Gemelli IRCCS (FPG), Università Cattolica del Sacro Cuore (UCSC)

Rome, Lazio, Italy

Amsterdam UMC

Amsterdam, South Holland, Netherlands

Franciscus Gasthuis & Vlietland

Rotterdam, South Holland, Netherlands

ULSSM - Unidade Local de Saúde Santa Maria, E.P.E

Lisbon, Portugal

Sacele Municipal Hospital

Săcele, Brașov County, Romania

Hospital Universitario Virgen del Rocío

Seville, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05651724

Related Trials

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT011434543 locations

Investigating the Impact of Obesity on Pubertal Development in Girls

NCT025836461 location

Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention

NCT019277831 location

Diabetes and Heart Disease Risk in Blacks

NCT000018531 location

Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction

NCT066527631 location